Stay Alert for Heart Patients Getting Clarithromycin
You'll hear about an increased risk of heart problems or death with clarithromycin (Biaxin) in heart patients...due to a new FDA warning.
Researchers are puzzled about the mechanism. And many experts are skeptical...the studies have flaws, and not all show a long-term risk.
Until we know more, we're telling pharmacists to consider a "better safe than sorry" approach with clarithromycin Rxs.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote